HomeInsightsResults

Kwality Pharmaceuticals Ltd Quarterly Result

Kwality Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 1.9 Cr

Volume Transacted

(Jan 6, 2025)

stocks purchased

21.2 K

Stocks Traded

(Jan 6, 2025)

Last Updated on: Jan 06, 2025

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

Net Profit

₹ 8.46

Last updated on: Jan 06, 2025

Key Highlights

  • The revenue of Kwality Pharmaceuticals Ltd for the Sep '24 is ₹ 90.26 crore as compare to the Jun '24 revenue of ₹ 80.36 crore. This represent the growth of 12.319564%.
  • The ebitda of Kwality Pharmaceuticals Ltd for the Sep '24 is ₹ 19.88 crore as compare to the Jun '24 ebitda of ₹ 17.62 crore. This represent the growth of 12.8263235%.
  • The net profit of Kwality Pharmaceuticals Ltd for the Sep '24 is ₹ 8.46 crore as compare to the Jun '24 net profit of ₹ 8.35 crore. This represent the growth of 1.3173611%.

Results Analysis

Market Price of Kwality Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Kwality Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Jan 2025902.4
03 Jan 2025923.05
02 Jan 2025904.7
01 Jan 2025867.3
31 Dec 2024866.8
30 Dec 2024870.5
27 Dec 2024888.9
26 Dec 2024877.85
24 Dec 2024896.65
23 Dec 2024879.8

Historical Revenue of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Kwality Pharmaceuticals Ltd News Hub

News

Kwality Pharmaceuticals update on pre-clinical studies of Erythropoietin

Kwality Pharmaceuticals (KPL) has secured approval from the Review Committee on Genetic Ma...

Read more

02 Jan 2025 15:37

News

Kwality Pharma gains on securing RCGM approval for Erythropoietin

Erythropoietin is a critical therapeutic used to treat anemia associated with chronic kidn...

Read more

02 Jan 2025 14:28

News

Kwality Pharma gains on securing SAHPRA approval for Tamoxifen tablet

The approval was granted through a site transfer process for the company's prominent oncol...

Read more

24 Dec 2024 15:07

News

Kwality Pharma gains on receiving nod for PEGylated-Asparaginase

L-Asparaginase is an E. coli-derived enzyme primarily used in the treatment of acute lymph...

Read more

26 Nov 2024 11:55

News

Kwality Pharmaceuticals to hold board meeting

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30...

Read more

23 Oct 2024 10:21

News

Kwality Pharmaceuticals schedules AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

10 Sep 2024 10:31

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Kwality Pharmaceuticals Ltd

What key financial metrics are included in Kwality Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Kwality Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Kwality Pharmaceuticals Ltd announce its quarterly results?

Kwality Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Kwality Pharmaceuticals Ltd's quarterly performance impact its stock price?

Kwality Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Kwality Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Kwality Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Kwality Pharmaceuticals Ltd's quarterly results?

Yes, Kwality Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions